The Case of Synthroid (B): Marketing a Drug Coming Off Patent

Kellogg School of Management Cases

ISSN: 2474-6568

Publication date: 20 January 2017

Abstract

After analyzing the case students should be able to:

  • Describe strategies that branded competitors can use to defend their business from lower-priced competition

  • Understand the basics of pharmaceutical marketing and pricing, including the global challenge of defending branded drugs against generic equivalents

  • Discuss ethical issues in the marketing of high-margin branded products that have lower-priced alternatives, especially in the healthcare industry

Keywords

Citation

Hennessy, J., Tybout, A., Fahey, N. and Snyder, C. (2017), "The Case of Synthroid (B): Marketing a Drug Coming Off Patent", Kellogg School of Management Cases. https://doi.org/10.1108/case.kellogg.2016.000344

Download as .RIS

Publisher

:

Kellogg School of Management

Copyright © 2013, The Kellogg School of Management at Northwestern University

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.